FDA Will Now Require Labeling of ADHD Medication to Indicate Weight Loss Risk

Agency will require a Limitation of Use section in the prescribing information of all extended-release ADHD stimulants
child scale weight
Adobe Stock
Published on
Updated on
Loading content, please wait...

Related Stories

No stories found.
logo
www.healthday.com